Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features

Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features

Abstract Background To develop a radiomics model based on chest computed tomography (CT) for the prediction of a pathological complete response (pCR) after neoadjuvant or conversion chemoimmunotherapy (CIT) in patients with non‐small cell lung cancer (NSCLC). Methods Patients with stage IB–III NSCLC...

Full description

Bibliographic Details
Main Authors: Nong Yang, Hai‐Lin Yue, Bai‐Hua Zhang, Juan Chen, Qian Chu, Jian‐Xin Wang, Xiao‐Ping Yu, Lian Jian, Ya‐Wen Bin, Si‐Ye Liu, Jin Liu, Liang Zeng, Hai‐Yan Yang, Chun‐Hua Zhou, Wen‐Juan Jiang, Li Liu, Yong‐Chang Zhang, Yi Xiong, Zhan Wang
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Thoracic Cancer
Subjects:
non‐small cell lung cancer
computed tomography
pathological response
predictive model
radiomics
Online Access:https://doi.org/10.1111/1759-7714.15052

Internet

https://doi.org/10.1111/1759-7714.15052

Similar Items